I Elomaa
Overview
Explore the profile of I Elomaa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
141
Citations
1494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Osterlund P, Ruotsalainen T, Korpela R, Saxelin M, Ollus A, Valta P, et al.
Br J Cancer
. 2007 Sep;
97(8):1028-34.
PMID: 17895895
5-Fluorouracil (5-FU)-based chemotherapy is frequently associated with diarrhoea. We compared two 5-FU-based regimens and the effect of Lactobacillus and fibre supplementation on treatment tolerability. Patients diagnosed with colorectal cancer (n=150)...
2.
Saarto T, Taube T, Blomqvist C, Vehmanen L, Elomaa I
Calcif Tissue Int
. 2005 Aug;
77(2):84-90.
PMID: 16075363
Bisphosphonates have been used successfully in the treatment of malignant hypercalcemia and skeletal metastases. Recently, clodronate has been studied in adjuvant settings in primary breast cancer. However, long-term effect of...
3.
Leppa S, Saarto T, Vehmanen L, Blomqvist C, Elomaa I
Breast Cancer Res Treat
. 2005 Apr;
90(2):117-25.
PMID: 15803358
Purpose: Serum postoperative matrix metalloproteinase 2 (MMP-2) level is a predictor of outcome in node positive breast cancer and can be used to stratify patients into low and high risk...
4.
Vehmanen L, Saarto T, Blomqvist C, Taskinen M, Elomaa I
Br J Cancer
. 2004 Jul;
91(3):476-81.
PMID: 15266329
In all, 146 premenopausal women with early stage breast cancer were treated with adjuvant chemotherapy. In addition, 5-year tamoxifen treatment was started after chemotherapy to those 112 patients with hormone-receptor-positive...
5.
Elomaa I, Joensuu H, Blomqvist C
Ann Oncol
. 2003 Apr;
14(5):699-703.
PMID: 12702522
Background: The purpose of this study was to determine the best tolerated and efficacious dose of vinorelbine given once or twice in 3-week cycles in combination with methotrexate and fluorouracil...
6.
Osterlund P, Orpana A, Elomaa I, Repo H, Joensuu H
Br J Cancer
. 2002 Sep;
87(6):591-9.
PMID: 12237767
We studied longitudinally inflammatory reactions and serum C-reactive protein (S-CRP) levels in 52 colorectal cancer patients treated with a median of six 3-weekly cycles of raltitrexed 1.5-3.0 mg m(-2) combined...
7.
Elomaa I, Kouri M, Kiviluoto T
Duodecim
. 2002 Aug;
117(18):1785-7.
PMID: 12181974
No abstract available.
8.
9.
10.
Vehmanen L, Saarto T, Elomaa I, Makela P, Valimaki M, Blomqvist C
Eur J Cancer
. 2001 Nov;
37(18):2373-8.
PMID: 11720830
We present the 5-year results of the effect of adjuvant chemotherapy on bone mineral density (BMD) and the efficacy of clodronate in the prevention of bone loss in 73 premenopausal...